An attempt was made to estimate the distribution of plasma HDL subclasses according to the levels of plasma lipids and apoproteins. Twenty-five normolipidemic patients, 25 hyperlipoproteinemic patients without CHD, and 28 CHD patients participated in this study. The distribution of plasma HDL subfractions was estimated by 4-30% gradient polyacrylamide gel electrophoresis (PAGE) of plasma fraction with a density of 1.21. The absolute amounts of HDL subfractions were obtained by multiplying HDL-C amounts by the percentage of HDL PAGE subclasses. Plasma concentrations of HDL
2b-C, HDL
2a-C, HDL
3a-C, HDL
3b-C and HDL
3c-C were 7.8±6.8mg/dl, 10.6±6.5mg/dl, 46.3±6.3mg/dl, 5.1±2.4mg/dl and 0.2±0.4mg/dl (mean±SD), respectively. Plasma HDL
2b-C amounts were positively correlated with HDL-C (r=0.721, p<0.001) and apo A-I (r=0.545, p<0.001) levels, but were not correlated with apo A-II. Plasma HDL
2a-C levels were positively correlated with HDL-C (r=0.638, p<0.001) concentrations, but were not correlated with apo A-II. The correlation coefficients with HDL-C and apo A-I were higher in HDL
2b-C levels than in HDL
2a-C levels. Plasma HDL
3a-C amounts were positively correlated with HDL-C (r=0.365, p<o.01), apo A-I (r=0.320, p<0.02) and apo A-II (r=0.470, p<0.001) levels. Plasma HDL
3b-C levels were positively correlated with apo A-I (r=0.287, p<0.02), apo A-II (r=0.530, p<0.001), apo C-II (r=0.420, p<0.001), apo C-III (r=0.344, p<0.01), and apo E (r=0.321, p<0.01) concentrations. Plasma HDL
3b-C levels were not correlated with HDL-C amounts. These results indicate the following. The concomitant changes of plasma HDL-C and apo A-I levels without apo A-II alteration suggest the alteration of HDL
2a and HDL
2b amounts, especially HDL
2b. Changes in HDL-C, apo A-I and apo A-II levels in the same direction reflect the alteration of HDL
3a amounts. HDL
3b might be heterogeneous because the plasma HDL
3b-C level was positively correlated with many kinds of apoprotein amounts. It was therefore concluded that the changes in HDL subfractions could be estimated by the measurement of plasma HDL-C and apoproteins.
View full abstract